Global Metabolomics Biomarker Market Growth (Status and Outlook) 2018-2023

Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms.

Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period. Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market.

Over the next five years, LPI(LP Information) projects that Metabolomics Biomarker will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Metabolomics Biomarker market for 2018-2023.

This report presents a comprehensive overview, market shares and growth opportunities of Metabolomics Biomarker market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

Gas chromatography

High-performance liquid chromatography

Nuclear magnetic resonance

Mass spectrometry

Surface-based mass analysis

Bioinformatics

Segmentation by application:

Toxicological studies

Drug testing

Cancer

Cardiovascular disorders

Neurological disorders

Inborn errors of metabolism

We can also provide the customized separate regional or country-level reports, for the following regions:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

Biocrates Life Sciences

Biomark Diagnostics

Chenomx

Creative Proteomics

Evotec

Human Metabolome Technologies

Merck

Metabolomic Diagnostics

Metabolon

Ovid Therapeutics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Metabolomics Biomarker market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Metabolomics Biomarker market by identifying its various subsegments.

Focuses on the key global Metabolomics Biomarker players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Metabolomics Biomarker with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Metabolomics Biomarker submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Metabolomics Biomarker Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Metabolomics Biomarker Market Size 2013-2023

2.1.2 Metabolomics Biomarker Market Size CAGR by Region

2.2 Metabolomics Biomarker Segment by Type

2.2.1 Gas chromatography

2.2.2 High-performance liquid chromatography

2.2.3 Ultra-performance liquid chromatography

2.2.4 Nuclear magnetic resonance

2.2.5 Mass spectrometry

2.2.6 Surface-based mass analysis

2.2.7 Bioinformatics

2.3 Metabolomics Biomarker Market Size by Type

2.3.1 Global Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

2.3.2 Global Metabolomics Biomarker Market Size Growth Rate by Type (2013-2018)

2.4 Metabolomics Biomarker Segment by Application

2.4.1 Toxicological studies

2.4.2 Drug testing

2.4.3 Cancer

2.4.4 Cardiovascular disorders

2.4.5 Neurological disorders

2.4.6 Inborn errors of metabolism

2.5 Metabolomics Biomarker Market Size by Application

2.5.1 Global Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

2.5.2 Global Metabolomics Biomarker Market Size Growth Rate by Application (2013-2018)

3 Global Metabolomics Biomarker by Players

3.1 Global Metabolomics Biomarker Market Size Market Share by Players

3.1.1 Global Metabolomics Biomarker Market Size by Players (2016-2018)

3.1.2 Global Metabolomics Biomarker Market Size Market Share by Players (2016-2018)

3.2 Global Metabolomics Biomarker Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Metabolomics Biomarker by Regions

4.1 Metabolomics Biomarker Market Size by Regions

4.2 Americas Metabolomics Biomarker Market Size Growth

4.3 APAC Metabolomics Biomarker Market Size Growth

4.4 Europe Metabolomics Biomarker Market Size Growth

4.5 Middle East & Africa Metabolomics Biomarker Market Size Growth

5 Americas

5.1 Americas Metabolomics Biomarker Market Size by Countries

5.2 Americas Metabolomics Biomarker Market Size by Type

5.3 Americas Metabolomics Biomarker Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Metabolomics Biomarker Market Size by Countries

6.2 APAC Metabolomics Biomarker Market Size by Type

6.3 APAC Metabolomics Biomarker Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Metabolomics Biomarker by Countries

7.2 Europe Metabolomics Biomarker Market Size by Type

7.3 Europe Metabolomics Biomarker Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Metabolomics Biomarker by Countries

8.2 Middle East & Africa Metabolomics Biomarker Market Size by Type

8.3 Middle East & Africa Metabolomics Biomarker Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Metabolomics Biomarker Market Forecast

10.1 Global Metabolomics Biomarker Market Size Forecast (2018-2023)

10.2 Global Metabolomics Biomarker Forecast by Regions

10.2.1 Global Metabolomics Biomarker Forecast by Regions (2018-2023)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Metabolomics Biomarker Forecast by Type

10.8 Global Metabolomics Biomarker Forecast by Application

11 Key Players Analysis

11.1 Biocrates Life Sciences

11.1.1 Company Details

11.1.2 Metabolomics Biomarker Product Offered

11.1.3 Biocrates Life Sciences Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.1.4 Main Business Overview

11.1.5 Biocrates Life Sciences News

11.2 Biomark Diagnostics

11.2.1 Company Details

11.2.2 Metabolomics Biomarker Product Offered

11.2.3 Biomark Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.2.4 Main Business Overview

11.2.5 Biomark Diagnostics News

11.3 Chenomx

11.3.1 Company Details

11.3.2 Metabolomics Biomarker Product Offered

11.3.3 Chenomx Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.3.4 Main Business Overview

11.3.5 Chenomx News

11.4 Creative Proteomics

11.4.1 Company Details

11.4.2 Metabolomics Biomarker Product Offered

11.4.3 Creative Proteomics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.4.4 Main Business Overview

11.4.5 Creative Proteomics News

11.5 Evotec

11.5.1 Company Details

11.5.2 Metabolomics Biomarker Product Offered

11.5.3 Evotec Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.5.4 Main Business Overview

11.5.5 Evotec News

11.6 Human Metabolome Technologies

11.6.1 Company Details

11.6.2 Metabolomics Biomarker Product Offered

11.6.3 Human Metabolome Technologies Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.6.4 Main Business Overview

11.6.5 Human Metabolome Technologies News

11.7 Merck

11.7.1 Company Details

11.7.2 Metabolomics Biomarker Product Offered

11.7.3 Merck Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.7.4 Main Business Overview

11.7.5 Merck News

11.8 Metabolomic Diagnostics

11.8.1 Company Details

11.8.2 Metabolomics Biomarker Product Offered

11.8.3 Metabolomic Diagnostics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.8.4 Main Business Overview

11.8.5 Metabolomic Diagnostics News

11.9 Metabolon

11.9.1 Company Details

11.9.2 Metabolomics Biomarker Product Offered

11.9.3 Metabolon Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.9.4 Main Business Overview

11.9.5 Metabolon News

11.10 Ovid Therapeutics

11.10.1 Company Details

11.10.2 Metabolomics Biomarker Product Offered

11.10.3 Ovid Therapeutics Metabolomics Biomarker Revenue, Gross Margin and Market Share (2016-2018)

11.10.4 Main Business Overview

11.10.5 Ovid Therapeutics News

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Metabolomics Biomarker

Figure Metabolomics Biomarker Report Years Considered

Figure Market Research Methodology

Figure Global Metabolomics Biomarker Market Size Growth Rate 2013-2023 ($ Millions)

Table Metabolomics Biomarker Market Size CAGR by Region 2013-2023 ($ Millions)

Table Major Players of Gas chromatography

Table Major Players of High-performance liquid chromatography

Table Major Players of Ultra-performance liquid chromatography

Table Major Players of Nuclear magnetic resonance

Table Major Players of Mass spectrometry

Table Major Players of Surface-based mass analysis

Table Major Players of Bioinformatics

Table Market Size by Type (2013-2018) ($ Millions)

Table Global Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

Figure Global Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

Figure Global Gas chromatography Market Size Growth Rate

Figure Global High-performance liquid chromatography Market Size Growth Rate

Figure Global Ultra-performance liquid chromatography Market Size Growth Rate

Figure Global Nuclear magnetic resonance Market Size Growth Rate

Figure Global Mass spectrometry Market Size Growth Rate

Figure Global Surface-based mass analysis Market Size Growth Rate

Figure Global Bioinformatics Market Size Growth Rate

Figure Metabolomics Biomarker Consumed in Toxicological studies

Figure Global Metabolomics Biomarker Market: Toxicological studies (2013-2018) ($ Millions)

Figure Global Toxicological studies YoY Growth ($ Millions)

Figure Metabolomics Biomarker Consumed in Drug testing

Figure Global Metabolomics Biomarker Market: Drug testing (2013-2018) ($ Millions)

Figure Global Drug testing YoY Growth ($ Millions)

Figure Metabolomics Biomarker Consumed in Cancer

Figure Global Metabolomics Biomarker Market: Cancer (2013-2018) ($ Millions)

Figure Global Cancer YoY Growth ($ Millions)

Figure Metabolomics Biomarker Consumed in Cardiovascular disorders

Figure Global Metabolomics Biomarker Market: Cardiovascular disorders (2013-2018) ($ Millions)

Figure Global Cardiovascular disorders YoY Growth ($ Millions)

Figure Metabolomics Biomarker Consumed in Neurological disorders

Figure Global Metabolomics Biomarker Market: Neurological disorders (2013-2018) ($ Millions)

Figure Global Neurological disorders YoY Growth ($ Millions)

Table Global Metabolomics Biomarker Market Size by Application (2013-2018) ($ Millions)

Table Global Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

Figure Global Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

Figure Global Metabolomics Biomarker Market Size in Toxicological studies Growth Rate

Figure Global Metabolomics Biomarker Market Size in Drug testing Growth Rate

Figure Global Metabolomics Biomarker Market Size in Cancer Growth Rate

Figure Global Metabolomics Biomarker Market Size in Cardiovascular disorders Growth Rate

Figure Global Metabolomics Biomarker Market Size in Neurological disorders Growth Rate

Figure Global Metabolomics Biomarker Market Size in Inborn errors of metabolism Growth Rate

Table Global Metabolomics Biomarker Revenue by Players (2016-2018) ($ Millions)

Table Global Metabolomics Biomarker Revenue Market Share by Players (2016-2018)

Figure Global Metabolomics Biomarker Revenue Market Share by Players in 2017

Table Global Metabolomics Biomarker Key Players Head office and Products Offered

Table Metabolomics Biomarker Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

Table Global Metabolomics Biomarker Market Size by Regions 2013-2018 ($ Millions)

Table Global Metabolomics Biomarker Market Size Market Share by Regions 2013-2018

Figure Global Metabolomics Biomarker Market Size Market Share by Regions 2013-2018

Figure Americas Metabolomics Biomarker Market Size 2013-2018 ($ Millions)

Figure APAC Metabolomics Biomarker Market Size 2013-2018 ($ Millions)

Figure Europe Metabolomics Biomarker Market Size 2013-2018 ($ Millions)

Figure Middle East & Africa Metabolomics Biomarker Market Size 2013-2018 ($ Millions)

Table Americas Metabolomics Biomarker Market Size by Countries (2013-2018) ($ Millions)

Table Americas Metabolomics Biomarker Market Size Market Share by Countries (2013-2018)

Figure Americas Metabolomics Biomarker Market Size Market Share by Countries in 2017

Table Americas Metabolomics Biomarker Market Size by Type (2013-2018) ($ Millions)

Table Americas Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

Figure Americas Metabolomics Biomarker Market Size Market Share by Type in 2017

Table Americas Metabolomics Biomarker Market Size by Application (2013-2018) ($ Millions)

Table Americas Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

Figure Americas Metabolomics Biomarker Market Size Market Share by Application in 2017

Figure United States Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Canada Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Mexico Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Table APAC Metabolomics Biomarker Market Size by Countries (2013-2018) ($ Millions)

Table APAC Metabolomics Biomarker Market Size Market Share by Countries (2013-2018)

Figure APAC Metabolomics Biomarker Market Size Market Share by Countries in 2017

Table APAC Metabolomics Biomarker Market Size by Type (2013-2018) ($ Millions)

Table APAC Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

Figure APAC Metabolomics Biomarker Market Size Market Share by Type in 2017

Table APAC Metabolomics Biomarker Market Size by Application (2013-2018) ($ Millions)

Table APAC Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

Figure APAC Metabolomics Biomarker Market Size Market Share by Application in 2017

Figure China Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Japan Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Korea Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Southeast Asia Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure India Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Australia Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Table Europe Metabolomics Biomarker Market Size by Countries (2013-2018) ($ Millions)

Table Europe Metabolomics Biomarker Market Size Market Share by Countries (2013-2018)

Figure Europe Metabolomics Biomarker Market Size Market Share by Countries in 2017

Table Europe Metabolomics Biomarker Market Size by Type (2013-2018) ($ Millions)

Table Europe Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

Figure Europe Metabolomics Biomarker Market Size Market Share by Type in 2017

Table Europe Metabolomics Biomarker Market Size by Application (2013-2018) ($ Millions)

Table Europe Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

Figure Europe Metabolomics Biomarker Market Size Market Share by Application in 2017

Figure Germany Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure France Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure UK Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Italy Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Russia Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Spain Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Table Middle East & Africa Metabolomics Biomarker Market Size by Countries (2013-2018) ($ Millions)

Table Middle East & Africa Metabolomics Biomarker Market Size Market Share by Countries (2013-2018)

Figure Middle East & Africa Metabolomics Biomarker Market Size Market Share by Countries in 2017

Table Middle East & Africa Metabolomics Biomarker Market Size by Type (2013-2018) ($ Millions)

Table Middle East & Africa Metabolomics Biomarker Market Size Market Share by Type (2013-2018)

Figure Middle East & Africa Metabolomics Biomarker Market Size Market Share by Type in 2017

Table Middle East & Africa Metabolomics Biomarker Market Size by Application (2013-2018) ($ Millions)

Table Middle East & Africa Metabolomics Biomarker Market Size Market Share by Application (2013-2018)

Figure Middle East & Africa Metabolomics Biomarker Market Size Market Share by Application in 2017

Figure Egypt Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure South Africa Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Israel Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Turkey Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure GCC Countries Metabolomics Biomarker Market Size Growth 2013-2018 ($ Millions)

Figure Global Metabolomics Biomarker arket Size Forecast (2018-2023) ($ Millions)

Table Global Metabolomics Biomarker Market Size Forecast by Regions (2018-2023) ($ Millions)

Table Global Metabolomics Biomarker Market Size Market Share Forecast by Regions

Figure Americas Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure APAC Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Europe Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Middle East & Africa Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure United States Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Canada Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Mexico Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Brazil Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure China Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Japan Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Korea Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Southeast Asia Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure India Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Australia Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Germany Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure France Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure UK Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Italy Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Russia Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Spain Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Egypt Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure South Africa Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Israel Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure Turkey Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Figure GCC Countries Metabolomics Biomarker Market Size 2018-2023 ($ Millions)

Table Global Metabolomics Biomarker Market Size Forecast by Type (2018-2023) ($ Millions)

Table Global Metabolomics Biomarker Market Size Market Share Forecast by Type (2018-2023)

Table Global Metabolomics Biomarker Market Size Forecast by Application (2018-2023) ($ Millions)

Table Global Metabolomics Biomarker Market Size Market Share Forecast by Application (2018-2023)

Table Biocrates Life Sciences Basic Information, Head Office, Major Market Areas and Its Competitors

Table Biocrates Life Sciences Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Biocrates Life Sciences Metabolomics Biomarker Market Share (2016-2018)

Table Biomark Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors

Table Biomark Diagnostics Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Biomark Diagnostics Metabolomics Biomarker Market Share (2016-2018)

Table Chenomx Basic Information, Head Office, Major Market Areas and Its Competitors

Table Chenomx Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Chenomx Metabolomics Biomarker Market Share (2016-2018)

Table Creative Proteomics Basic Information, Head Office, Major Market Areas and Its Competitors

Table Creative Proteomics Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Creative Proteomics Metabolomics Biomarker Market Share (2016-2018)

Table Evotec Basic Information, Head Office, Major Market Areas and Its Competitors

Table Evotec Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Evotec Metabolomics Biomarker Market Share (2016-2018)

Table Human Metabolome Technologies Basic Information, Head Office, Major Market Areas and Its Competitors

Table Human Metabolome Technologies Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Human Metabolome Technologies Metabolomics Biomarker Market Share (2016-2018)

Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors

Table Merck Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Merck Metabolomics Biomarker Market Share (2016-2018)

Table Metabolomic Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors

Table Metabolomic Diagnostics Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Metabolomic Diagnostics Metabolomics Biomarker Market Share (2016-2018)

Table Metabolon Basic Information, Head Office, Major Market Areas and Its Competitors

Table Metabolon Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Metabolon Metabolomics Biomarker Market Share (2016-2018)

Table Ovid Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors

Table Ovid Therapeutics Metabolomics Biomarker Revenue and Gross Margin (2016-2018)

Figure Ovid Therapeutics Metabolomics Biomarker Market Share (2016-2018)

Enquiryform

Purchase